SNP information rs763110

Research and publications:

  15937082   Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.

  18757527   Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer.

  18759263   Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.

  18805939   Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis

  18854777   Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy.

  19240174   Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.

  19337311   The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies.

  19941645   Fas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South Africans.

  20106900   International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

  20219325   Polymorphisms of FAS and FAS ligand genes and risk of skin cancer.

  20385987   Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma.

  20438363   Fas and FasL polymorphisms are not associated with acute myeloid leukemia risk in Koreans.

  20959405   The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.

  21160888   Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions

  21807637   A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.

  21864388   Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians

  21926110   Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa.

  22022540   Human FasL gene is a target of β-catenin/T-cell factor pathway and complex FasL haplotypes alter promoter functions.

  22732091   FASL-844 T/C polymorphism: a biomarker of good prognosis of breast cancer in the Tunisian population.

  23141929   A controlled case study of the relationship between environmental risk factors and apoptotic gene polymorphism and lumbar disc herniation.

  23185509   Genetic association studies in lumbar disc degeneration: a systematic review.

  23392773   Association of apoptosis-related Fas and FasL gene polymorphisms with knee osteoarthritis.

  23720679   Prognostic assessment of apoptotic gene polymorphisms in non-small cell lung cancer in Chinese.

  23749041   Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.

  24248546   Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.

  24424626   Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.

  24587306   Death receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian population.

  24690069   Association of functional polymorphisms in FAS and FAS Ligand genes promoter with pre-eclampsia.

  24918007   Clinical and genetic factors predicting response to therapy in patients with Crohn's disease.

  24931268   The role of functional polymorphisms in immune response genes as biomarkers of bacille Calmette-Guérin (BCG) immunotherapy outcome in bladder cancer: establishment of a predictive profile in a Southern Europe population.

  25075970   The associations between immunity-related genes and breast cancer prognosis in Korean women.

  25645050   Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.

  25928231   Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis.

  25976983   Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy.

  26602921   A Multiple Interaction Analysis Reveals ADRB3 as a Potential Candidate for Gallbladder Cancer Predisposition via a Complex Interaction with Other Candidate Gene Variations.

  26759270   FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin.

  26788026   Analysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucoma.

  26819081   Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.

  26858129   Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.

  26861312   Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease.

  26905515   Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.

  27009330   Single nucleotide polymorphisms in apoptosis pathway are associated with response to imatinib therapy in chronic myeloid leukemia.

  27121382   Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model.

  27417569   Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.

  27524883   Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.

  27603042   The FAS-670 AA genotype is associated with high proviral load in peruvian HAM/TSP patients.

  27790710   A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of C/EBPβ and OCT1 complex to chromatin.

  27895396   Genetic alterations in hepatocellular carcinoma: An update.

  27977511   Rituximab response in follicular lymphoma is associated with the rs20575 polymorphism in TRAILR1 extrinsic apoptosis trigger.

  28442396   Fas and Fas ligand gene polymorphisms in Turkish patients with Familial Mediterranean Fever.

  28603427   Pharmacogenetics in inflammatory bowel disease: understanding treatment response and personalizing therapeutic strategies.

  28652652   Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update.

  28785150   Genetic polymorphisms predict response to antitumor necrosis factor treatment in Crohn's disease.

  28827732   Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies.

  28850937   Effect modification by apoptosis-related gene polymorphisms on the associations of phthalate exposure with spermatozoa apoptosis and semen quality.

  28971183   Interaction between polyunsaturated fatty acids and genetic variants in relation to breast cancer incidence.

  29611722   Single-Nucleotide Polymorphisms of FAS and FASL Genes and Risk of Idiopathic Aplastic Anemia.

  29652777   Meta-Analysis of the Association Between FAS Ligand and TRAIL Genetic Polymorphisms and Intervertebral Disc Degeneration Susceptibility in Chinese Han population.

  29734947   Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.

  30065912   Variants of FasL and ABCC5 are predictive of outcome after chemotherapy-based treatment in osteosarcoma.

  30616520   Interaction between TP53 and XRCC1 increases susceptibility to cervical cancer development: a case control study.

  30937706   The role of FAS, FAS-L, BAX, and BCL-2 gene polymorphisms in determining susceptibility to unexplained recurrent pregnancy loss.

  31425784   Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis.

  31428123   Systematic Review of Genetic Factors in the Etiology of Esophageal Squamous Cell Carcinoma in African Populations.

  31516756   Genetic polymorphisms and gastric cancer risk: a comprehensive review synopsis from meta-analysis and genome-wide association studies.

  32209020   Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations.

  33659210   A Review of Cancer Genetics and Genomics Studies in Africa.

  33973562   A Case-control Study of Major Genetic Predisposition Risk Alleles in Developing DDD in the Northeast US Population: Effects of Gene-gene Interactions.

  34127318   Relationship between polymorphisms in the FAS/FASL death receptor system and progression of low-grade precursor lesions infected with high-risk human papilloma virus.

  34366198   Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.

  34540891   Umbrella Review on Associations Between Single Nucleotide Polymorphisms and Lung Cancer Risk.

  35988104   The role of FASL, BCL-2 and BAX polymorphisms in brazilian patients with prostate cancer and benign prostatic hyperplasia.

  35998845   Role of Polymorphisms on the Recurrent Pregnancy Loss: A Systematic Review, Meta-analysis and Bioinformatic Analysis.